Susan Hasty, Publisher
Table of Contents . . . July 25th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Adjuvants - GFP-A2/CTB Complexes Could Broaden Horizons Of Cholera Toxin-Based Vaccines
Influenza B - Revaccination Effective In Rare Cases of Hib Vaccine Failure
Asthma - M. Vaccae Immunization Fails To Stop Asthma
Breast Cancer - Vaccination With MUC1 Peptide Is Effective Against Tumors In Vitro
Chlamydia - New mAb Vaccine Protects Mice From Human C. Trachomatis Strain
Helicobacter pylori - Lactococcus Lactis Fails To Deliver Protection
Influenza - Long-term Care Facilities Should Do More To Encourage Staff Vaccination
Renal Cancer - GM-CSF, IL-6 Boost Efficacy of Autologous Tumor Cell Vaccine
Cholera - V. Cholerae O139 Antigen Induces Immune Responses In Mice
Delivery Systems - New Generation Adenovirus Vectors Overcome Preexisting Immunity
Dental Caries - Antigen For Vaccine Discovered
Disease Prevention - Study Ranks Effectiveness Of Common Preventive Medicine
HIV Vaccines - First Trinidadian Volunteer Injected With Experimental Combination
Infectious Disease - Risks Mount In The United States
Influenza - Health Officials Expect Another Flu Vaccine Delay
Malignant Melanoma - Clinical Trial Of Cancer Vaccine Initiated
Monoclonal Antibodies - Preclinical And Clinical Advances To Headline At Conference
Non-Hodgkin Lymphoma - Radiolabeled Humanized CD22 Antibody Shows Promise
Pediatrics - Immunity After DTaP-HBV Vaccine Comparable With Natural Infection
Psoriasis - Siplizumab Safe And Well Tolerated In Clinical Trials
Psoriasis - Three Humanized Antibodies In Clinical Development
Sexually Transmitted Diseases - Findings For Bovine Trichomoniasis Vaccine May Be Applicable To Humans
Vaccine Safety - Varicella Vaccine Does Not Increase Risk of Birth Defects
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.